(Q37800999)

23 August 2017

title

Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? (English)

1 reference

23 August 2017

0 references

4

Joan Montaner

1 reference

23 August 2017

Anna Morancho

1

1 reference

23 August 2017

Anna Rosell

series ordinal

2

1 reference

23 August 2017

Lidia García-Bonilla

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Annals of the New York Academy of Sciences

23 August 2017

published in

1 reference

23 August 2017

volume

1207

1 reference

23 August 2017

page(s)

123-133

1 reference

Inflammatory mechanisms after ischemia and stroke

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05734.X

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05734.X

Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05734.X

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05734.X

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05734.X

10.1111/J.1749-6632.2010.05734.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference